{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T22:13:15Z","timestamp":1784585595083,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Inland Norway"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Vet Scand"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Wild and captive European moose (\n                      <jats:italic>Alces alces alces<\/jats:italic>\n                      ) are routinely anesthetized with drug combinations including alpha-2 adrenoceptor agonists, dissociative anesthetics, and opioids. Reportedly, severe respiratory depression, ventilation\/perfusion (V\/Q) mismatch, and hypoxemia are common complications in this species, requiring perianesthetic oxygen supplementation as key treatment, athough high flow rates can exacerbate respiratory acidosis. Salbutamol is a \u03b2\n                      <jats:sub>2<\/jats:sub>\n                      -adrenoceptor agonist effective in alleviating V\/Q mismatch and hypoxemia in anesthetized horses when administered via endotracheal tube. Administration of salbutamol could elicit similar effects in anesthetized moose, improving animal welfare and perhaps reducing or replacing the supplemental oxygen requirements.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      Three healthy captive moose (two juveniles, male and female, and one adult male) underwent four anesthetic events for routine zoo health assessments. One juvenile was anesthetized again after 15 days and served as its own control. Moose were anesthetized with medetomidine (0.05\u20130.08 mg kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      ), ketamine (1.7\u20132.8 mg kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      ), and butorphanol (0.04\u20130.07 mg kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      ) intramuscularly (IM). Intranasal oxygen (1 L min\n                      <jats:sup>\u22121<\/jats:sup>\n                      100 kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      ) was administered, and they were allocated to receive either 10 mL saline (control) or aerosolized salbutamol. Salbutamol was administered incrementally at 200, 400 and 800 \u00b5g 100 kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      , with 10-minute monitoring intervals following each dose, using one of three methods: a spacer, an equine intranasal (IN) tube, or an equine medical mask. Invasive blood pressure, electrocardiogram, respiratory rate, SpO2, and rectal temperature were recorded every 5 min. Arterial blood gases and electrolytes were measured before oxygen supplementation and both before and 10 min after each salbutamol dose. Anesthesia was reversed with IM atipamezole (0.3\u20130.4 mg kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      ), and all moose were monitored for seven days post-anesthesia for adverse effects. All moose were hypoxemic, hypercapnic, hypertensive, and tachypneic. No hypotension or hypokalemia occurred. PaO\u2082 increased in all individuals, with no consistent difference between treatment and control. The largest PaO\u2082 increase occurred in the moose receiving salbutamol via the IN tube. Other physiological variables remained stable. Recoveries were uneventful, with no adverse effects observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Aerosolized salbutamol was well tolerated, but did not provide a clear benefit for hypoxemia compared to placebo. Further studies with higher salbutamol doses, alternative delivery routes, or modified anesthetic protocols are recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13028-026-00856-7","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T02:55:51Z","timestamp":1770519351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and adverse effects of three delivery methods for aerosolized salbutamol in anesthetized European moose (Alces alces alces): a case series"],"prefix":"10.1186","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9767-7488","authenticated-orcid":false,"given":"Jacopo","family":"Morelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Hoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Heiderich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Stettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dany","family":"Elzahaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina L.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,8]]},"reference":[{"key":"856_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/bph.12695","volume":"172","author":"AJ Chabot-Dor\u00e9","year":"2015","unstructured":"Chabot-Dor\u00e9 AJ, Schuster DJ, Stone LS, Wilcox GL. Analgesic synergy between opioid and \u03b12 -adrenoceptors. Br J Pharmacol. 2015;172:388\u2013402.","journal-title":"Br J Pharmacol"},{"key":"856_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13028-014-0051-5","volume":"56","author":"M Lian","year":"2014","unstructured":"Lian M, Evans AL, Bertelsen MF, Fahlman \u00c5, Haga HA, Ericsson G, et al. Improvement of arterial oxygenation in free-ranging moose (Alces alces) immobilized with etorphine-acepromazine-xylazine. Acta Vet Scand. 2014;56:51.","journal-title":"Acta Vet Scand"},{"key":"856_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1751-0147-54-77","volume":"54","author":"AL Evans","year":"2012","unstructured":"Evans AL, Fahlman \u00c5, Ericsson G, Haga HA, Arnemo JM. Physiological evaluation of free-ranging moose (Alces alces) immobilized with etorphine-xylazine-acepromazine in Northern Sweden. Acta Vet Scand. 2012;54:77.","journal-title":"Acta Vet Scand"},{"key":"856_CR4","doi-asserted-by":"publisher","first-page":"103944","DOI":"10.1016\/j.jevs.2022.103944","volume":"113","author":"SC Clark-Price","year":"2022","unstructured":"Clark-Price SC, Lascola KM, Auckburally A, Boone LH, Caldwell FJ, Weatherall KM, et al. The effect of inhaled albuterol on PaO2 in anesthetized horses receiving a FiO2 of 0.5 or >\u20090.95. J Equine Vet Sci. 2022;113:103944.","journal-title":"J Equine Vet Sci"},{"key":"856_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1046\/j.1467-2995.2002.00100.x","volume":"29","author":"SA Robertson","year":"2002","unstructured":"Robertson SA, Bailey JE. Aerosolized salbutamol (albuterol) improves PaO2 in hypoxaemic anaesthetized horses - a prospective clinical trial in 81 horses. Vet Anaesth Analg. 2002;29:212\u20138.","journal-title":"Vet Anaesth Analg"},{"issue":"Suppl B","key":"856_CR6","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1053\/rmed.2001.1139","volume":"95","author":"J L\u00f6tvall","year":"2001","unstructured":"L\u00f6tvall J. Pharmacological similarities and differences between beta2-agonists. Respir Med. 2001;95(Suppl B):S7\u201311.","journal-title":"Respir Med"},{"key":"856_CR7","doi-asserted-by":"publisher","first-page":"103667","DOI":"10.1016\/j.jevs.2021.103667","volume":"103","author":"K Loomes","year":"2021","unstructured":"Loomes K. Effect of aerosolised salbutamol administration on arterial potassium concentration in anaesthetised horses. J Equine Vet Sci. 2021;103:103667.","journal-title":"J Equine Vet Sci"},{"key":"856_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13028-014-0049-z","volume":"56","author":"D Casoni","year":"2014","unstructured":"Casoni D, Spadavecchia C, Adami C. Cardiovascular changes after administration of aerosolized salbutamol in horses: five cases. Acta Vet Scand. 2014;56:49.","journal-title":"Acta Vet Scand"},{"key":"856_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cveq.2016.11.007","volume":"33","author":"ML Cha","year":"2017","unstructured":"Cha ML, Costa LR. Inhalation therapy in horses. Vet Clin North Am Equine Pract. 2017;33:29\u201346.","journal-title":"Vet Clin North Am Equine Pract"},{"key":"856_CR10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.vaa.2019.10.011","volume":"47","author":"J Einwaller","year":"2020","unstructured":"Einwaller J, Painer J, Raekallio M, Gasch K, Restitutti F, Auer U, et al. Cardiovascular effects of intravenous Vatinoxan (MK-467) in medetomidine-tiletamine-zolazepam anaesthetised red deer (Cervus elaphus). Vet Anaesth Analg. 2020;47:518\u201327.","journal-title":"Vet Anaesth Analg"},{"key":"856_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/jvp.12354","volume":"40","author":"RS Pirie","year":"2017","unstructured":"Pirie RS, McGorum BC, Owen C, Carr O, Oakley H, McLachlan G. Factors affecting the efficiency of aerosolized salbutamol delivery via a metered dose inhaler and equine spacer device. J Vet Pharmacol Ther. 2017;40:231\u20138.","journal-title":"J Vet Pharmacol Ther"},{"key":"856_CR12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ar.24022","volume":"302","author":"S M\u00e1rquez","year":"2019","unstructured":"M\u00e1rquez S, Pagano AS, Mongle CS, Albertine KH, Laitman JT. The nasal complex of a semiaquatic artiodactyl, the moose (Alces alces): is it a good evolutionary model for the ancestors of cetaceans? Anat Rec. 2019;302:667\u201392.","journal-title":"Anat Rec"},{"key":"856_CR13","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1183\/09031936.94.07091707","volume":"7","author":"PW Barry","year":"1994","unstructured":"Barry PW, O\u2019Callaghan C. Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range. Eur Respir J. 1994;7:1707\u20139.","journal-title":"Eur Respir J"},{"key":"856_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/0970-2113.197116","volume":"34","author":"M Sarkar","year":"2017","unstructured":"Sarkar M, Niranjan N, Banyal PK. Mechanisms of hypoxemia. Lung India. 2017;34:47\u201360.","journal-title":"Lung India"},{"key":"856_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.2042-3306.1995.tb03045.x","volume":"27","author":"Y Moens","year":"1995","unstructured":"Moens Y, Lagerweij E, Gootjes P, Poortman J. Distribution of inspired gas to each lung in the anaesthetised horse and influence of body shape. Equine Vet J. 1995;27:110\u20136.","journal-title":"Equine Vet J"},{"key":"856_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1467-2995.2008.00400.x","volume":"35","author":"JC Mansel","year":"2008","unstructured":"Mansel JC, Clutton RE. The influence of body mass and thoracic dimensions on arterial oxygenation in anaesthetized horses and ponies. Vet Anaesth Analg. 2008;35:392\u20139.","journal-title":"Vet Anaesth Analg"},{"key":"856_CR17","doi-asserted-by":"crossref","unstructured":"Stefanik E, Drewnowska O, Lisowska B, Turek B. Causes, effects and methods of monitoring gas exchange disturbances during equine general anaesthesia. Anim (Basel). 2021;11.","DOI":"10.3390\/ani11072049"},{"key":"856_CR18","doi-asserted-by":"crossref","unstructured":"Ramseyer A, Sides R, Slinker B, Evans D, Bayly W. Evaluation of a mask for breath-by-breath respirometry during exercise in horses. Equine Vet J Suppl. 2010:240\u20135.","DOI":"10.1111\/j.2042-3306.2010.00250.x"},{"key":"856_CR19","doi-asserted-by":"crossref","unstructured":"Moreno-Martinez F, Byrne D, Raisis A, Waldmann AD, Hosgood G, Mosing M. Comparison of effects of an endotracheal tube or facemask on breathing pattern and distribution of ventilation in anesthetized horses. Front Vet Sci. 2022;9.","DOI":"10.3389\/fvets.2022.895268"}],"container-title":["Acta Veterinaria Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13028-026-00856-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13028-026-00856-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13028-026-00856-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:36:01Z","timestamp":1771508161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13028-026-00856-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,8]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["856"],"URL":"https:\/\/doi.org\/10.1186\/s13028-026-00856-7","relation":{},"ISSN":["1751-0147"],"issn-type":[{"value":"1751-0147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,8]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The salbutamol clinical trial was reviewed and approved by Bern Animal Park (IACUC approval number TPB23-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Data have not been published previously.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Prior publication"}},{"value":"The consent for publication of the recorded datasets and multimedia additional files was granted by Bern Animal Park.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}